Jordan Kempker is a Respiratory physician affiliated with Emory University. OpenAlex indexes 96 publications with 1,734 citations (h-index 20).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
69 Jesse Hill Jr Dr SE
Atlanta, GA 303033033
Telephone
404-616-7028Registry record last updated 23 Sept 2015.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- GlaxoSmithKline, LLC.Program year20231 payment
- Chiesi USA, Inc.Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
81.8%Corticosteroid34.1%Symbicort53%Fluticasone Propionate47%Part D<11 patientsbeta2-Adrenergic Agonist31.8%Albuterol Sulfate Hfa100%Part D≥12 patients+ 1 more class in this area
Metabolism & gastrointestinal
18.2%Corticosteroid18.2%Prednisone100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2018–2020 per NIH RePORTER. The latest:
- A Geographic Approach to Determining the Preventable Causes of US Sepsis Mortality
Emory University
FY2020$150,228K08HS025240 - A Geographic Approach to Determining the Preventable Causes of US Sepsis Mortality
Emory University
FY2019$150,228K08HS025240 - A Geographic Approach to Determining the Preventable Causes of US Sepsis Mortality
Emory University
FY2018$150,476K08HS025240
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Optimal Timing of Adjuvant Therapy in Patients with Poorly Differentiated Pancreatic Adenocarcinoma
Annals of Surgical Oncology
2026 - Preventing, identifying, and managing sepsis in the community: research and clinical priorities
The Lancet Primary Care
2025 - Validation of SeptiCyte RAPID to Discriminate Sepsis from Non-Infectious Systemic Inflammation
Journal of Clinical Medicine
2024
Similar KOLs
Other experts from the same institution or the same specialty.
James Lah, MD
Emory University
Keith Delman, MD
Emory University
John Puskas, MD
Emory University
Craig Hofmeister, MD
Emory University
Fernando Martinez, MD
University of Massachusetts Chan Medical School
David Gozal, MD
Ronald Crystal, MD
Weill Cornell Medicine
Bartolome Celli, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”